“What’s New in Diabetes Management? A Focus on Transitions of Care”
Event Navigation
HealthTrust presents…“What’s New in Diabetes Management? A Focus on Transitions of Care”
Download a copy of this content.
Please Note: Continuing education credit is only available to those who attend the live session. CE credit is not available when accessing the program on demand.
This session will begin with a brief overview of the updated 2021 ADA guidelines, focused on agents recommended for compelling indications of increased ASCVD risk, heart failure and CKD. We will analyze pertinent trials surrounding SGLT‐2 Inhibitors and GLP1 receptor agonists, compare/ contrast agents in each class and discuss how to handle these medications from a transitions of care standpoint. This will include criteria for initiation and monitoring upon hospital discharge. The presentation will conclude with a review of the phase II trial of once weekly insulin and a discussion about transitions of care aspects surrounding this new medication.
Learning Objectives for Pharmacists & Nurses | At the end of this session, participants should be able to:
1. Discuss indications and place in therapy for the new antihyperglycemic agents.
2. Identify key differences between the GLP‐1 analogs and the SGLT‐2 Inhibitors.
3. Describe the role of the new diabetes agents within a transitions of care plan.
Learning Objectives for Pharmacy Technicians | At the end of this session, participants should be able to:
1. Identify medications within the same class to ensure there is not duplication of therapies while obtaining medication history.
2. Outline common lab parameters used to assess the effectiveness of diabetes treatment.
3. Describe different storage requirements for recommended agents.
Presenter:
Jaclyn O’Connor, PharmD | PGY‐1 Pharmacy Resident | Atlantic Health System
Target Audience: Pharmacists, Pharmacy Techs & Nurses
Continuing Education Information: 1.0 contact hours approved for Nurses, Pharmacists and Pharmacy Techs. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-21-048-L01-P and 0863-9999-21-048-L01-T. The activity is approved for 1 hour of continuing education credit to nurses, pharmacists and pharmacy techs who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.
Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
